Fieldpoint Private Securities’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$4.44M Sell
28,999
-7,154
-20% -$1.1M 1.29% 11
2022
Q1
$5.86M Buy
36,153
+972
+3% +$158K 1.21% 9
2021
Q4
$4.76M Buy
35,181
+381
+1% +$51.6K 0.93% 16
2021
Q3
$3.75M Buy
34,800
+92
+0.3% +$9.92K 0.83% 22
2021
Q2
$3.99M Buy
34,708
+1,420
+4% +$163K 0.87% 22
2021
Q1
$3.6M Sell
33,288
-2,487
-7% -$269K 0.84% 23
2020
Q4
$3.83M Buy
35,775
+8,951
+33% +$959K 0.87% 25
2020
Q3
$2.35M Buy
26,824
+480
+2% +$42.1K 0.69% 35
2020
Q2
$2.59M Sell
26,344
-11,698
-31% -$1.15M 0.87% 30
2020
Q1
$2.9M Buy
38,042
+780
+2% +$59.4K 1.12% 21
2019
Q4
$3.3M Buy
37,262
+18,639
+100% +$1.65M 0.97% 23
2019
Q3
$1.41M Sell
18,623
-156
-0.8% -$11.8K 0.51% 55
2019
Q2
$1.37M Buy
18,779
+1,794
+11% +$130K 0.43% 61
2019
Q1
$1.37M Hold
16,985
0.57% 51
2018
Q4
$1.57M Sell
16,985
-487
-3% -$44.9K 0.69% 41
2018
Q3
$1.65M Hold
17,472
0.63% 44
2018
Q2
$1.62M Hold
17,472
0.62% 46
2018
Q1
$1.65M Sell
17,472
-4,670
-21% -$442K 0.75% 35
2017
Q4
$2.14M Sell
22,142
-1,195
-5% -$116K 1.13% 22
2017
Q3
$2.07M Buy
23,337
+1,157
+5% +$103K 0.89% 25
2017
Q2
$1.61M Sell
22,180
-750
-3% -$54.4K 1.1% 14
2017
Q1
$1.49M Buy
+22,930
New +$1.49M 1.16% 26